chr9-2029073-G-C
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003070.5(SMARCA2):āc.51G>Cā(p.Pro17=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000593 in 1,568,920 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. P17P) has been classified as Likely benign.
Frequency
Consequence
NM_003070.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMARCA2 | NM_003070.5 | c.51G>C | p.Pro17= | synonymous_variant | 2/34 | ENST00000349721.8 | |
SMARCA2 | NM_001289396.1 | c.51G>C | p.Pro17= | synonymous_variant | 2/34 | ||
SMARCA2 | NM_139045.4 | c.51G>C | p.Pro17= | synonymous_variant | 2/33 | ||
SMARCA2 | NM_001289397.2 | c.51G>C | p.Pro17= | synonymous_variant | 2/33 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMARCA2 | ENST00000349721.8 | c.51G>C | p.Pro17= | synonymous_variant | 2/34 | 5 | NM_003070.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000663 AC: 12AN: 181082Hom.: 0 AF XY: 0.0000616 AC XY: 6AN XY: 97350
GnomAD4 exome AF: 0.0000374 AC: 53AN: 1416700Hom.: 1 Cov.: 32 AF XY: 0.0000371 AC XY: 26AN XY: 700870
GnomAD4 genome AF: 0.000263 AC: 40AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74360
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 02, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 24, 2019 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
SMARCA2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 22, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at